TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07630584: Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements: A Double-blind, Randomized Placebo-controlled Nutritional Study

Sponsor: Société des Produits Nestlé (SPN) · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 327 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07630584 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07630584 Rescue Dossier →